{"id":254,"date":"2023-06-09T23:45:22","date_gmt":"2023-06-10T06:45:22","guid":{"rendered":"https:\/\/blogs.ubc.ca\/gibsonlab\/?page_id=254"},"modified":"2025-11-06T15:22:02","modified_gmt":"2025-11-06T22:22:02","slug":"industry-partner","status":"publish","type":"page","link":"https:\/\/blogs.ubc.ca\/gibsonlab\/industry-partner\/","title":{"rendered":"Partners"},"content":{"rendered":"\n

Melius MicroBiomics Inc.<\/h2><\/div>\n\n\n\n
\n

Dr. Deanna Gibson is the Co-Founder, Co-Inventor and current Non-Executive Chief Science Advisor of Melius. <\/span>She also previously served as the Chief Scientific Officer at Melius.<\/p>\n<\/div>\n\n\n\n

\n

The Gibson Lab created two genetically engineered microbial medicines (GEMM\u2122<\/span>), BioPersist\u2122 & BioColonize\u2122. Melius MicroBiomics Inc. has licensed this UBC IP to take these products to market. <\/span>Visit our website here<\/a>. Learn more about the story behind Melius and GEMM technology here<\/a>. <\/p>\n<\/div>\n\n\n\n

\"\"<\/figure>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

GROW<\/h2>\n\n\n\n

(Glyphosate Research on forest Organisms and Wildlife health)<\/h5>\n\n\n\n
\n
\n
<\/span>
\n
\"\"<\/figure>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n

The GROW project aims to investigate the effect of glyphosate-based herbicides on the forest on the forest ecosystem and wildlife in Canada. <\/p>\n\n\n\n

In collaboration with Swan River First Nation, the Lheidli T’enneh First Nation, the British Columbia Wildlife Federation, and the British Columbia and Alberta Trappers Associations, we hope to elucidate the impact of glyphosate and their residues on environmental microbiome, and gut microbiome and hormone levels of wildlife. <\/p>\n\n\n\n

For more information, please visit here<\/a>. <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Dr. Deanna Gibson is the Co-Founder, Co-Inventor and current Non-Executive Chief Science Advisor of Melius. She also previously served as the Chief Scientific Officer at Melius. The Gibson Lab created two genetically engineered microbial medicines (GEMM\u2122), BioPersist\u2122 & BioColonize\u2122. Melius MicroBiomics Inc. has licensed this UBC IP to take these products to market. Visit our website here. […]<\/p>\n","protected":false},"author":96603,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-254","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/pages\/254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/users\/96603"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/comments?post=254"}],"version-history":[{"count":36,"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/pages\/254\/revisions"}],"predecessor-version":[{"id":626,"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/pages\/254\/revisions\/626"}],"wp:attachment":[{"href":"https:\/\/blogs.ubc.ca\/gibsonlab\/wp-json\/wp\/v2\/media?parent=254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}